Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis.
Anastasilakis AD, Papachatzopoulos S, Makras P, Gkiomisi A, Nikolakopoulos P, Polyzos SA, Ntenti C, Ballaouri I, Gerou S, Tsachouridou O, Papatheodorou A, Aliazis K, Fermanoglou S, Bisbinas I, Yavropoulou MP. Anastasilakis AD, et al. Among authors: bisbinas i. Bone. 2022 May;158:116354. doi: 10.1016/j.bone.2022.116354. Epub 2022 Feb 9. Bone. 2022. PMID: 35150909
Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.
Anastasilakis AD, Polyzos SA, Makras P, Gkiomisi A, Bisbinas I, Katsarou A, Filippaios A, Mantzoros CS. Anastasilakis AD, et al. Among authors: bisbinas i. Osteoporos Int. 2014 May;25(5):1633-42. doi: 10.1007/s00198-014-2673-x. Epub 2014 Mar 6. Osteoporos Int. 2014. PMID: 24599275
Denosumab versus zoledronic acid in patients previously treated with zoledronic acid.
Anastasilakis AD, Polyzos SA, Gkiomisi A, Saridakis ZG, Digkas D, Bisbinas I, Sakellariou GT, Papatheodorou A, Kokkoris P, Makras P. Anastasilakis AD, et al. Among authors: bisbinas i. Osteoporos Int. 2015 Oct;26(10):2521-7. doi: 10.1007/s00198-015-3174-2. Epub 2015 May 20. Osteoporos Int. 2015. PMID: 25990355 Clinical Trial.
No effect of rosuvastatin in the zoledronate-induced acute-phase response.
Makras P, Anastasilakis AD, Polyzos SA, Bisbinas I, Sakellariou GT, Papapoulos SE. Makras P, et al. Among authors: bisbinas i. Calcif Tissue Int. 2011 May;88(5):402-8. doi: 10.1007/s00223-011-9468-2. Epub 2011 Feb 9. Calcif Tissue Int. 2011. PMID: 21305270 Clinical Trial.
Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P. Anastasilakis AD, et al. Among authors: bisbinas i. J Clin Endocrinol Metab. 2013 Aug;98(8):3206-12. doi: 10.1210/jc.2013-1402. Epub 2013 Jun 20. J Clin Endocrinol Metab. 2013. PMID: 23788684 Clinical Trial.
59 results